MassBio 3rd Annual ED+I Conference

August 18, 2020 10:00 AM - 12:15 PM

Webinar, click "live-stream" button to view

Add to Calendar 8/18/2020 10:00:00 AM 8/18/2020 12:15:00 PM MassBio 3rd Annual ED+I Conference

Due to the ongoing concern around the spread of COVID-19, and to ensure the health and safety of all participants, we will be hosting MassBio’s 3rd Annual ED+I Conference virtually via Zoom on Tuesday, August 18th, 2020 at 10:00 am EST – 12:15 PM EST.
 

So much has happened since the last MassBio Annual ED+I Conference. As a country, we learned from this global pandemic the value of science, crisis preparedness, what information to believe, and which leaders to follow. Throughout it all, industry collaboration was key to improvement. Diversity and inclusion of resources, experiences, and perspectives were vital to our development of diagnostics, therapies, and vaccines. The life sciences industry demonstrated that diversity is fundamental to innovation and creativity, and to navigate this unprecedented crisis.
 

MassBio 3rd Annual ED+I Conference will give attendees the opportunity to:

- Connect with industry experts and peers
- Talk about the role of leaders in intentional conversations about racism
- Share insight and fresh ideas around your current recruiting, retention, and development challenges
- Explore non-traditional ways to build cultural intelligence and improve the employee experience that results in a highly productive workforce
- Learn how to create an ethos of values, respect, and support
- Balance deliverables and well-being during these unprecedented times
- Keep our high-risk and vulnerable teammates engaged and safe in the New Normal
- Learn what the ‘Next Normal’ should look like


For sponsorship opportunities contact Edie Stringfellow.
 

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Webinar, click "live-stream" button to view
Director & Patient Engagement Lead, Internal Medicine Research Unit, Pfizer
Dr. Ann-Marie La Ronde-Richard is Director and Patient Engagement Lead in the Internal Medicine Research Unit at Pfizer. Formerly Principal Scientist in the Metabolic Disease Unit and with over 16 years of pharmaceutical industry experience, Dr. La Ronde-Richard is in a unique position to bridge the gap between researchers and patients, ensuring that researchers better understand the experiences and unmet medical needs of diverse patient populations living with chronic metabolic diseases. Her role entails partnering with Patient Advocacy Groups, patients and their families to ensure that patients’ perspectives and needs are incorporated into the drug development strategy from beginning to end to ultimately improve health outcomes for all. Throughout her 16+ years at Pfizer, Dr. La Ronde-Richard has been actively involved in driving DEI initiatives aligned with Pfizer’s business remit. She served as Chair of the Global Blacks Community (GBC) – Greater Boston branch (a Pfizer Colleague Resource Group, CRGs) for 8 yrs, working to create a diverse and inclusive workplace and one where everyone has equal opportunities to meet their full potential. During her tenure as Chair, Pfizer’s GBC Greater Boston was an instrumental founding member of the Color of Biotech, Massachusetts, a partnership amongst CRGs across Pharma/Biotech in Massachusetts that created a community for collaboration, networking, support and innovation amongst professionals of color in Greater Boston’s growing Biotechnology sector. Dr. La Ronde-Richard was born and raised on the beautiful island of Dominica in the Eastern Caribbean and migrated to the United States in 1991 to further her education. She obtained her B.S. degree from Suffolk University in Boston and then completed her Doctorate in Pathology at Boston University School of Medicine. Dr. La Ronde-Richard is the cofounder of the Dominican Health and Education Initiative (DAHEI), a 501c3 organization founded in 2013, focused on improving the quality of life for individuals, families and communities, including in her native island, Dominica, through enhancing education, healthcare and training.

Brought to you by